Aldeyra Therapeutics Inc’s recently made public that its 10% Owner PERCEPTIVE ADVISORS LLC acquired Company’s shares for reported $1.27 million on Apr 03 ’24. In the deal valued at $4.09 per share,309,847 shares were bought. As a result of this transaction, PERCEPTIVE ADVISORS LLC now holds 9,097,858 shares worth roughly $42.94 million.
Then, PERCEPTIVE ADVISORS LLC bought 186,051 shares, generating $640,015 in total proceeds. Upon buying the shares at $3.44, the 10% Owner now owns 8,788,011 shares.
Before that, PERCEPTIVE ADVISORS LLC bought 8,374 shares. Aldeyra Therapeutics Inc shares valued at $27,216 were divested by the 10% Owner at a price of $3.25 per share. As a result of the transaction, PERCEPTIVE ADVISORS LLC now holds 8,601,960 shares, worth roughly $40.6 million.
Oppenheimer upgraded its Aldeyra Therapeutics Inc [ALDX] rating to an Outperform from a a Perform in a research note published recently. H.C. Wainwright started covering the stock on February 08, 2021. It rated ALDX as “a Buy”.
Price Performance Review of ALDX
On Friday, Aldeyra Therapeutics Inc [NASDAQ:ALDX] saw its stock jump 0.75% to $4.72. Over the last five days, the stock has gained 44.34%. Aldeyra Therapeutics Inc shares have risen nearly 34.47% since the year began. Nevertheless, the stocks have fallen -52.42% over the past one year. While a 52-week high of $11.97 was reached on 04/05/24, a 52-week low of $1.42 was recorded on 03/15/24. SMA at 50 days reached $3.39, while 200 days put it at $4.72. A total of 1.47 million shares were traded, compared to the trading of 2.32 million shares in the previous session.
Levels Of Support And Resistance For ALDX Stock
The 24-hour chart illustrates a support level at 4.54, which if violated will result in even more drops to 4.37. On the upside, there is a resistance level at 4.93. A further resistance level may holdings at 5.15. The Relative Strength Index (RSI) on the 14-day chart is 78.68, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.17, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.26%. Stochastics %K at 91.70% indicates the stock is a selling.
How much short interest is there in Aldeyra Therapeutics Inc?
A steep rise in short interest was recorded in Aldeyra Therapeutics Inc stocks on Mar 15, 2024, dropping by 100000.0 shares to a total of 1.83 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 1.93 million shares. There was a decline of -5.46%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 3.94% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.26.
The most recent change occurred on December 16, 2020 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
